The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.
The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.
Patent No.:
Date of Patent:
Apr. 12, 2016
Filed:
Apr. 30, 2013
Applicant:
Takeda Gmbh, Constance, DE;
Inventors:
Angelika Hoffmeyer, Constance, DE;
Rainer Boer, Constance, DE;
Manuela Hessmann, Grossensee, DE;
Andreas Pahl, Heidelberg, DE;
Torsten Dunkern, Juchen, DE;
Simone Hartung, Allensbach, DE;
Christof Zitt, Constance, DE;
Jurgen Volz, Radolfzell, DE;
Christiane Praechter, Hamburg, DE;
Mahindra Makhija, Mumbai, IN;
Hiteshkumar Jain, Mumbai, IN;
Sandip Gavade, Mumbai, IN;
Arati Prabhu, Mumbai, IN;
Manojkumar Tiwari, Maharashtra, IN;
Ashish Keche, Maharashtra, IN;
Sarvesh Patel, Maharashtra, IN;
Assignee:
Takeda GmbH, Constance, DE;
Primary Examiner:
Assistant Examiner:
Int. Cl.
CPC ...
C07D 265/30 (2006.01); C07C 233/81 (2006.01); C07C 233/75 (2006.01); C07C 235/66 (2006.01); C07C 237/40 (2006.01); C07C 237/42 (2006.01); C07D 295/155 (2006.01); A61K 31/196 (2006.01); A61K 31/27 (2006.01); A61K 31/4453 (2006.01); A61K 31/495 (2006.01); A61K 31/5375 (2006.01); A61K 45/06 (2006.01); C07C 237/52 (2006.01); C07C 271/42 (2006.01);
U.S. Cl.
CPC ...
C07C 233/81 (2013.01); A61K 31/196 (2013.01); A61K 31/27 (2013.01); A61K 31/4453 (2013.01); A61K 31/495 (2013.01); A61K 31/5375 (2013.01); A61K 45/06 (2013.01); C07C 233/75 (2013.01); C07C 235/66 (2013.01); C07C 237/40 (2013.01); C07C 237/42 (2013.01); C07C 237/52 (2013.01); C07C 271/42 (2013.01); C07D 295/155 (2013.01);
Abstract
The compounds of formula (1) in which R1, R4, A and X have the meanings as given in the description, are novel effective EP2 agonists.